BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4660224)

  • 1. Induction of abortion by extra-ammiotic prostaglandin administration.
    Wiqvist N; Béguin F; Bygdeman M; Fernström I; Toppozada M
    Prostaglandins; 1972 Jan; 1(1):37-53. PubMed ID: 4660224
    [No Abstract]   [Full Text] [Related]  

  • 2. Laminaria augmentation of intra-amniotic prostaglandin F2 alpha for the induction of mid-trimester abortion.
    Brenner WE; Hendricks CH; Dingfelder J; Staurovsky L
    Prostaglandins; 1973 Jun; 3(6):879-94. PubMed ID: 4729606
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of abortion by intra- and extra-amniotic prostaglandin F2 administration.
    Järvinen PA; Pennanen S; Ylöstalo P
    Prostaglandins; 1973 Apr; 3(4):491-504. PubMed ID: 4729587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-amniotic prostaglandin PGF2alpha (THAM salt) and the laminaria tent in midtrimester termination of pregnancy.
    Berman R; Hale RW; Reich LA; Pion RJ
    Contraception; 1974 Jun; 9(6):635-42. PubMed ID: 4448090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The abortifacient action of the extraovular "prostaglandin impact" during the first half of human pregnancy.
    Enkola K
    Prostaglandins; 1974 Jan; 5(1):115-21. PubMed ID: 4816714
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of therapeutic abortion using either extra-amniotic prostaglandin F-2-alpha or hypertonic saline followed by oxytocin.
    Lange AP; Secher NJ; Pedersen GT
    Prostaglandins; 1974 Apr; 6(2):149-57. PubMed ID: 4847514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal administration of prostaglandin F2alpha for inducing therapeutic abortion.
    Brenner WE; Hendricks CH; Braaksma JT; Fishburne JI; Staurovsky LG
    Prostaglandins; 1972 Jun; 1(6):455-67. PubMed ID: 4660080
    [No Abstract]   [Full Text] [Related]  

  • 8. Cervical priming before first trimester aspiration abortion: a single blind study comparing gemeprost 1 mg and prostaglandin E2 10 mg pessaries.
    Mackenzie IZ; Jackson C; Mckinlay E; Millar J
    J Obstet Gynaecol (Lahore); 1990 Oct; 10(6):513-7. PubMed ID: 12284145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginally administered PGF2alpha for cervical dilatation in nulliparas prior to suction curettage.
    Brenner WE; Dingfelder JR; Staurovsky LG; Hendricks CH
    Prostaglandins; 1973 Dec; 4(6):819-36. PubMed ID: 4783581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-amniotic prostaglandin E 2 and F 2 for induction of abortion: a dose response study.
    Craft I
    J Obstet Gynaecol Br Commonw; 1973 Jan; 80(1):46-7. PubMed ID: 4572299
    [No Abstract]   [Full Text] [Related]  

  • 11. Termination of early gestation with intramuscular (15S)-15 methyl prostaglandin F2 alpha.
    Brenner PF; Lumkin ME; Ballard C; Mishell DR
    Contraception; 1975 Mar; 11(3):279-87. PubMed ID: 1116367
    [No Abstract]   [Full Text] [Related]  

  • 12. Rupture of the cervix in prostaglandin abortions.
    Kajanoja P; Jungner G; Widholm O; Karjalainen O; Seppälä M
    J Obstet Gynaecol Br Commonw; 1974 Mar; 81(3):242-4. PubMed ID: 4821484
    [No Abstract]   [Full Text] [Related]  

  • 13. On the mechanism of midtrimester abortions induced by prostaglandin "impact".
    Saldana L; Schulman H; Yang WH
    Prostaglandins; 1973 Jun; 3(6):847-58. PubMed ID: 4729604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic abortion with the use of prostaglandin F 2 . A study of efficacy, tolerance, and plasma levels with intravenous administration.
    Gillett PG; Kinch RA; Wolfe LS; Pace-Asciak C
    Am J Obstet Gynecol; 1972 Feb; 112(3):330-8. PubMed ID: 5060379
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of an intracervical prostaglandin E2 preparation, Cerviprost, on cervical ripening before first trimester abortion in nulliparous patients.
    Irvine LM; Shaw RW
    J Obstet Gynaecol (Lahore); 1989; 10(2):120-3. PubMed ID: 12283723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Termination of early gestation with vaginal prostaglandin F2 alpha tablets.
    Corlett RC; Sribyatta B; Mishell DR; Ballard C; Nakamura RM; Thorneycroft IH
    Prostaglandins; 1972 Dec; 2(6):453-64. PubMed ID: 4666665
    [No Abstract]   [Full Text] [Related]  

  • 18. Cervical dilatation with prostaglandin analogues prior to vaginal termination of first trimester pregnancy in nulliparous patients.
    Karim SM; Choo HT; Cheng P
    Prostaglandins; 1975 Apr; 9(4):631-8. PubMed ID: 1153813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and acceptability of 15(S)-15-methyl-prostaglandin E2-methyl ester for midtrimester pregnancy termination.
    Bieniarz J; Hunter G; Scommegna A
    Am J Obstet Gynecol; 1974 Nov; 120(6):840-3. PubMed ID: 4429095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mid-trimester abortion with 15 (S) methyl prostaglandin F 2 alpha.
    Leibman T; Saldana L; Schulman H; Cunningham MA; Randolph G
    Prostaglandins; 1974 Sep; 7(5):443-8. PubMed ID: 4424912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.